Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Evotec, Sernova Striving for Functional Diabetes Cure
Evotec, Sernova Striving for Functional Diabetes Cure
Two life sciences powerhouses are coming together to develop an off-the-shelf beta cell replacement therapy for insulin-dependent diabetes patients, which they hope will become a functional cure f...
Otsuka Ends Partnership With Akebia Over CRL-Related CKD Anemia Drug
Otsuka Ends Partnership With Akebia Over CRL-Related CKD Anemia Drug
Otsuka Pharmaceutical said it is ending a collaboration with Akebia Therapeutics over the investigational chronic kidney disease-associated anemia drug vadadustat. ...
NICE Recommends AstraZeneca’s Imfinzi for NSCLC
NICE Recommends AstraZeneca’s Imfinzi for NSCLC
The UK’s National Institute for Health and Care Excellence (NICE) is recommending AstraZeneca’s Imfinzi (durvalumab) for National Health Service (NHS) use in treating patients with locally adva...
FDA Authorizes First COVID-19 Test Available without a Prescription That Also Detects Flu and RSV
FDA Authorizes First COVID-19 Test Available without a Prescription That Also Detects Flu and RSV
Today, the U.S. Food and Drug Administration authorized the Labcorp Seasonal Respiratory Virus RT-PCR DTC Test for use without a prescription by individuals with symptoms of respiratory viral infec...
Fujirebio’s Diagnostic Test for Beta-amyloid Plaques Given FDA OK
Fujirebio’s Diagnostic Test for Beta-amyloid Plaques Given FDA OK
The U.S. Food and Drug Administration (FDA) has granted marketing permission to a new test that checks for amyloid plaques in people being checked for Alzheimer’s disease. ...
Flu causes cardiac complications by directly infecting the heart
Flu causes cardiac complications by directly infecting the heart
Researchers have shown for the first time in mice that heart problems associated with the flu are not caused by raging inflammation in the lungs, as has long been predicted. ...
NICE Recommends Gedeon Richter’s Ryeqo for Uterine Fibroids
NICE Recommends Gedeon Richter’s Ryeqo for Uterine Fibroids
The UK’s National Institute for Health and Care Excellence (NICE) is recommending Gedeon Richter’s Ryeqo (relugolix, estradiol and norethisterone acetate) for National Health Service use for t...
Lilly’s new drug Mounjaro (tirzepatide ) wins US FDA approval
Lilly’s new drug Mounjaro (tirzepatide ) wins US FDA approval

Blood sugar control drug Mounjaro has been granted US regulatory approval, giving type 2 diabetics another way to help keep their glucose levels in check.

Aurobindo Gets Hit With Another Form 483
Aurobindo Gets Hit With Another Form 483
Aurobindo Pharma has taken another hit from the FDA after an inspection of its oral drug manufacturing facility in Hyderabad, India, earlier this month resulted in a Form 483 report with six observ...
UCB Psoriasis Drug Will Need to Wait for US Approval
UCB Psoriasis Drug Will Need to Wait for US Approval
It won't be a happy weekend for UCB as the U.S. Food and Drug Administration issued a Complete Response Letter (CRL) to the Belgium-based company regarding its Biologics License Application (BLA) f...
PolarityTE Announces FDA Regenerative Medicine Advanced Therapy Designation Granted to SkinTE®
PolarityTE Announces FDA Regenerative Medicine Advanced Therapy Designation Granted to SkinTE®
PolarityTE, Inc. (Nasdaq: PTE) today announced that the U.S. Food and Drug Administration (FDA) granted a Regenerative Medicine Advanced Therapy (RMAT) designation to SkinTE under the Company's op...
FDA Approves Oral Form for the treatment of adults with amyotrophic lateral sclerosis (ALS)
FDA Approves Oral Form for the treatment of adults with amyotrophic lateral sclerosis (ALS)

FDA has approved Radicava ORS (edaravone) oral suspension for the treatment of adults with amyotrophic lateral sclerosis (ALS).

Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand